World of DTC Marketing

DECEMBER 10, 2021

Massive layoffs could be headed to Biogen due to the disappointing rollout of its Alzheimer’s drug Aduhelm that generated only a few million dollars in revenue over the past two quarters. Today, STAT News is reporting that they could lay off as many as 1,000 people to save $750 million.

Drugs 231

Drugs Marketing Development 231

Crucial Data Soutions

FEBRUARY 8, 2023

The news surrounding recent mass layoffs has been hard to miss and may even have you taking a closer look at the companies you choose to do business with. When it comes to evaluating vendors for your eClinical solutions, here are a few positive attributes to look for that serve as a recipe for longevity and sustainability.

52

52

Intouch Solutions

DECEMBER 7, 2022

Justin Chase, SVP, Media, EVERSANA INTOUCH, was recently interviewed by Endpoints News for an article on how pharmaceutical companies are handling both paid and organic interaction on Twitter in the era of Elon Musk ownership. It really is a challenge with so many Americans using the platform and valuing the platform.”

Life Science 52

Life Science Pharma Companies Branding Marketing 52

World of DTC Marketing

SEPTEMBER 23, 2021

Yesterday STAT news reported that because of the slow uptake of their Alzheimer’s drug, they might be forced to change business plans which include layoffs. Then there is the tale of Biogen. To me, this says that the approval of the drug WAS about money, not patients.

Vaccination 214

Vaccination Vaccine Drugs Packaging 214

Intouch Solutions

FEBRUARY 8, 2022

It’s not exactly news to say that COVID-19 has been a catalyst for monumental changes in the healthcare industry. So what does that mean, and what will it look like, especially as sales rep layoffs and let-gos continue, and physicians say they want more real-world data and a lot less selling ?

Sales 52

Sales Clinical Trials Clinical Trials Marketing 52

World of DTC Marketing

JANUARY 24, 2022

When they tell small biotech companies to cut costs, there will often be a significant delay in getting the drug to market or massive layoffs of needed staff. That investment, equal to the National Institutes of Health’s annual spending on medical research, would seem like great news for a world waiting for help with a pandemic.

Life Science 225

Life Science Drugs Genetic Disease Development 225

Intouch Solutions

NOVEMBER 11, 2022

Mark Zuckerberg’s multi-billion-dollar Meta empire has been on the wrong side of the news recently – poor user numbers, mass layoffs (MarketWatch) and overall confusion (NY Times, subscription req’d). Billions Being Spent In Metaverse Land Grab (BBC News) On the other hand, maybe Zuck’s aspirations are right after all?

Branding 52

Branding Marketing Pharmacy Engineer 52

pharmaphorum

AUGUST 13, 2020

New York Magazine , the New York Times and The Economist amongst many other news organisations knocked down their paywalls for COVID-19-related coverage to keep readers informed in a rapidly changing and often confusing environment. At Delta Airlines, the CEO ripped up his pay-check for the year to try and diminish layoffs.

Branding 85

Branding Vaccination Vaccine Filler 85

XTalks

SEPTEMBER 14, 2020

The most important news out of Europe was the €750 billion ($1.16 The most promising news about any drug thus far in the pandemic just came out of the UK where Southampton researchers together with Synairgen showed that an inhaled form of interferon-? ECONOMIC IMPACT: Europe and the United Kingdom. Drugs and Vaccines.

Vaccination 92

Vaccination Vaccine Antibody Life Science 92

Pharmaceutical Technology

JANUARY 25, 2023

News of layoffs and restructuring have evoked concerns that 2023 could be a year of attrition that will push companies to prioritise key candidates and hold onto their finances. While the stock market indices may be down by 40%, the market cap of some companies is down by 90%, leading to news of restructurings and closures, says Ryan.

Marketing 173

Marketing Life Science Pharma Companies Licensing 173